Skip to main content
. Author manuscript; available in PMC: 2010 Oct 13.
Published in final edited form as: Cancer Chemother Pharmacol. 2009 Jun 13;65(3):419–425. doi: 10.1007/s00280-009-1044-3

Table 2.

Simultaneous plasma and CSF PK parameters after a single 5 mg/kg dose in non-human primates

Animal τ (h) Ka (h −1) V1/F (L/kg) Ke (h −1) K12 (h−1) K21 (h −1)
t1/2P(h)
CSF CL (ml/h)
1 0.76 12.5 41.5 0.23 7.0 × 10−6 0.805 3.0 8.1
2 0.78 53.5 40.0 0.18 4.7 × 10−6 0.420 3.9 4.2
3 2.75 44.2 24.2 0.16 16.5 × 10−6 0.913 4.3 9.1
Mean 1.43 36.7 35.2 0.19 9.4 × 10−6 0.71 3.7 7.1
SD 1.14 21.5 9.6 0.04 6.3 × 10−6 0.26 0.7 2.6

τ time-delay for absorption of oral drug, Ka absorption rate constant, V1/F model-estimated apparent volume of distribution, Ke plasma elimination rate constant, K12 rate constant for transfer from plasma to CSF, K21 rate constant for transfer from CSF to plasma, t1/2P model-estimated plasma half-life, CSF CL clearance from CSF